WEARABLES WILL TRANSFORM THE HEALTHCARE INDUSTRY
“We’ve only unlocked a small proportion of the PSE and Lifetouch’s capabilities”
“We’ve only unlocked a small proportion of the PSE and Lifetouch’s capabilities”
Response to growing demand from NHS and health organisations puts Isansys Lifecare in leading position
Proof-of-concept study establishes how Isansys Lifetouch™ ‘smart bandage’ can facilitate early problem recognition and intervention in patients suffering from advanced liver disease
Isansys’ vital signs monitoring platform recognised as a leading technology for innovation and change in healthcare delivery
Sepsis kills 37,000 patients needlessly every year Now a ground-breaking wireless patient digitisation platform is being extended for home use to red-flag early signs of sepsis within 72 hours for chemotherapy patients
Welcome to the Isansys Lifecare blog, launched as part of our campaign to communicate the benefits of the Patient Status Engine platform and new generation wireless vital signs monitors and the integral role it can and will play in enabling healthcare specialists to discover new ways to help their patients in hospitals and at home 24 hours a day.
Isansys’ vital signs monitoring platform recognised as a leading technology for innovation and change in healthcare delivery
Isansys’ vital signs monitoring platform recognised by NHS England as a leading technology for innovation and change in healthcare delivery
Isansys has been invited to demo the Patient Status Engine at an upcoming Health 2.0 London event being held on Wednesday 9th October (6.30 – 9.00pm).
Fully approved and scalable patient digitisation platform enables unprecedented Insights into the clinical status of one or hundreds of patients
Technology Strategy Board and private investors help fund widescale hospital deployments of Isansys Patient Status Engine and extension to paediatric use
Isansys is featured in the new whitepaper from leading analyst firm IMS Research. The whitepaper, Wearable Technology – A Global Market Overview, is a complimentary piece of research based on IMS Research's recent report World Market for Wearable Technology – A Quantitative Market Assessment – 2012.
Isansys provides remote monitoring solutions which improve patient care, drive clinical performance, ensure economic value and enhance patient safety.
Headquartered in Oxfordshire, with subsidiaries in Germany, India and the US, Isansys is a privately limited company which was founded in 2010 by Keith Errey and Rebecca Weir.
Our business is to work with health professionals, insurance companies and healthcare organisations to provide more efficient patient monitoring against a backdrop of staff shortages and a rising number of patients and costs and limited budgets.
All our products and devices are fully certified and qualified medical devices.
8C Park Square
OX14 4RR Oxford
United Kingdom